Previous Article | Next Article 
Journal of Virology, November 1999, p. 9178-9186, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Sequence and Insertion Sites of Murine
Melanoma-Associated Retrovirus
Mengfeng
Li,*
Xiaojun
Huang,
Zhenyu
Zhu, and
Elieser
Gorelik
University of Pittsburgh Cancer Institute and
Department of Pathology, University of Pittsburgh, Pittsburgh,
Pennsylvania 15213
Received 27 July 1999/Accepted 16 August 1999
 |
ABSTRACT |
We previously showed that B16 melanoma cells produce
ecotropic melanoma-associated retrovirus (MelARV) which
encodes a melanoma-associated antigen recognized by MM2-9B6 monoclonal
antibody. The biological significance of MelARV in melanoma formation
remains unknown. We found that infection of normal melanocytes with
MelARV resulted in malignant transformation. It is likely that MelARV
emerged from the defective Emv-2 provirus, a single copy of ecotropic provirus existing in the genome of C57BL/6 mice. In the present study,
we cloned and sequenced the full-length MelARV genome and its insertion
sites and we completed sequencing of the Emv-2 provirus. Our data show
that MelARV has a typical full-length retroviral genome with high
homology (98.54%) to Emv-2, indicating a close relationship between
both viruses. MelARV probably emerged as a result of recombination
between Emv-2 and an endogenous nonecotropic provirus. Some
observed differences in the gag and pol
regions of MelARV might account for the restoration of productivity and infectivity of a novel retrovirus that somatically emerged during melanoma formation. MelARV does not contain any oncogene and therefore might induce transformation by insertional mutagenesis. We sequenced two insertion sites of MelARV. The first insertion site
represents the 3' coding region of the c-maf proto-oncogene
at 67.0 centimorgans (cM) on chromosome 8. The c-maf
proto-oncogene encodes a basic leucine zipper protein homologous to
c-fos and c-jun. Insertion of MelARV in BL6
melanoma cells resulted in the up-regulation of c-maf. It
is noteworthy that the Emv-2 provirus is also inserted into a noncoding
region at 61.0 cM on the same chromosome 8. The second insertion site
is the 3' noncoding region of the DNA polymerase gamma (PolG) gene on
chromosome 7. The expression of PolG was not affected by the
MelARV insertion. Further investigation of the biological significance
of MelARV in melanoma formation is being undertaken.
 |
INTRODUCTION |
All strains of laboratory
mice have proved to contain endogenous retroviral sequences in their
genomes (13, 16, 19, and 20). These sequences encode
retroviruses that are morphologically classified as A, B, and C type
(19). Type A retroviruses are known as intracisternal A
particles (IAPs), which assemble on intracellular membranes and bud
into cisternae of the endoplasmic reticulum. A mouse contains about
1,000 copies of IAP proviral elements per haploid genome
(21). IAPs are generally absent in normal tissues but are
abundant in some malignant cells such as plasmacytomas, neuroblastomas,
and teratocarcinomas (21). The B-type retrovirus group
includes as infectious agents only the mouse mammary tumor viruses
(MMTVs) which induce mammary adenocarcinoma formation in some strains
of mice. Several genetic loci that are associated with production of
MMTV, and mammary tumors have been identified (19). C-type
murine retroviruses were initially identified in murine
lymphomas/leukemias, which were thereafter termed murine leukemia
viruses (MuLVs). According to their ability to invade cells of
different species, MuLVs are divided into several classes: ecotropic,
xenotropic, or polytropic. Generally, a murine genome contains numerous
copies of xenotropic or polytropic proviruses. Most inbred strains of
mice, however, contain one to two ecotropic proviruses, while the AKR
strain has three ecotropic proviruses and this strain of mice is
characterized by high production of ecotropic MuLV early in life and
high incidence of development of spontaneous lymphomas. Some strains of
mice such as DBA/2, C3H, or C57BL/6 produce virus spontaneously only
late in life or not at all. Usually, a very low incidence of
spontaneous lymphomas is observed in these mice (19). We
have recently found that a B16 melanoma that spontaneously originated
in C57BL/6 mice produces A- and C-type retroviral particles (25,
26, 30). We have cloned and sequenced an IAP from BL6 melanoma
cells (25). A 9-base motif in the R region showed that the
melanoma-derived IAP differs from other previously sequenced IAPs and
thus it was termed melanoma-associated IAP (25). B16
melanoma and all its high- and low-metastatic sublines produce numerous
C-type retroviral particles that encode an antigen that is recognizable
by MM2-9B6 monoclonal antibody (MAb) (24). This
antigen is also expressed by other melanomas (JB/RH and JB/MS)
that originated in C57BL/6 mice but not by normal or malignant cells of
different histological types. Therefore, this antigen has been termed
melanoma-associated antigen (MAA). It was found that MM2-9B6 MAb
directed against MAA could lead to eradication of pulmonary and liver
metastases (7, 11). We found that MAA is encoded by the
env region of a C-type retrovirus (26). This
retrovirus was identified as B-tropic ecotropic retrovirus
(24) and has been designated melanoma-associated retrovirus (MelARV) (26). It is of note that the Cloudman
S91 melanoma that was spontaneously developed in DBA/2 mice and the UV-induced K1735 melanoma of C3H mice also produce ecotropic
retroviruses. However, the retrovirus-encoded antigen in these
melanomas does not react with MM2-9B6 MAb (24). It is
possible that the env region of the MelARV from melanomas of
DBA/2 and C3H mice does not contain an epitope that is present in the
MelARV from C57BL/6 mice and thus the MM2-9B6 MAb fails to react with
these melanomas. MuLVs were initially found in murine
lymphoma/leukemia. The finding of MuLVs in murine melanomas raises the
question of what their biological significance is and whether they play
a role in melanoma formation. The ecotropic MelARV in B16 melanoma
cells probably originated from the endogenous ecotropic provirus Emv-2
that exists in all cells of C57BL/6 mice. However, this provirus is
defective and is unable to generate replication-competent retrovirus.
The defect in Emv-2 was mapped to nucleotide 3576 by the substitution of alanine for proline in the pol gene
(17). It is possible that the MelARV in melanomas of C57BL/6
mice emerged as a result of a recombination between ecotropic Emv-2 and
nonecotropic sequences during malignant transformation or tumor
progression. MelARV in melanomas of other strains of mice might result
from recombination between different partners. For example, in Cloudman
S91 melanoma of DBA/2 mice, MelARV might be a descendant of Emv-3 that
resides in the genome of DBA/2 mice. In K1735 melanoma, MelARV
might contain env sequences from Emv-4 or Emv-5 of C3H mice.
This might explain the differences between the reactions of melanomas
of C57BL/6 and those of other strains of mice to MM2-9B6 MAb.
Therefore, it is of interest to clone and sequence MelARV and
determine how unique or how common the MelARV is to the already well-characterized and sequenced ecotropic MuLVs. In the present study we have cloned and sequenced the complete genome of MelARV from
B16 melanoma. In order to understand the origin of MelARV, it is
important to compare the MelARV nucleotide and amino acid sequences
with those of the endogenous ecotropic Emv-2 provirus that might be a
precursor of the MelARV. However, Emv-2 was only partially sequenced
(17). Therefore, we also sequenced the entire genome of
Emv-2 and performed a full comparative analysis of MelARV and Emv-2 as
well as the previously sequenced Emv-11 of AKR mice (12).
The role of MuLVs in malignant transformation has been mostly
investigated in malignancies of hematopoetic origins. The existence of
ecotropic MuLV in melanoma cells raises the question of whether MelARV
production is incidental to or rather, whether it plays a pathogenic
role in melanoma formation and progression. To test this possibility,
we recently infected two melanocyte culture lines derived from C57BL/6
mice with MelARV from cell-free supernatant of BL6 melanoma cells.
Normal melanocyte cells are able to grow in vitro only in the presence
of 12-O-tetradecanolphorbol-13-acetate (TPA). In most cases,
infection of melanocytes with MelARV resulted in the appearance of MAAs
recognized by MM2-9B6 MAb without changes in their morphology and their
dependence on TPA. In two cases, melanocytes showed morphological
changes and were able to grow in vitro in the absence of TPA and after
inoculation into mice, formation of the progressively growing highly
pigmented tumors was observed. These MelARV-transformed melanomas were
termed Meli-A and Meli-BL, respectively (27).
It is believed that there are two major mechanisms used by murine
retroviruses to cause malignancies: (i) some MuLVs, like Abelson virus,
contain an oncogene and can induce malignant transformation at a high
frequency, practically in each infected cell, and (ii) the vast
majority of MuLVs do not carry an oncogene, but instead they integrate
into cellular genomes, which results in the insertional mutagenesis of
certain cellular proto-oncogenes or tumor suppressor genes (for a
review, see reference 37). Based on the relatively low frequencies of malignant transformation of normal melanocytes, it
seems unlikely that the MelARV derived from B16 melanoma is a
transforming retrovirus. It is more likely that the MelARV is a typical
MuLV and its ability to transform melanocytes depends on its ability to
insert into a cellular proto-oncogene(s) or tumor suppressor gene(s)
and to change its expression or functions. Analysis of retrovirus
insertion sites in MuLV-induced lymphoma/leukemia has been found to be
a very fruitful approach in identification of numerous genes that are
involved in leukemogenesis (1).
It is possible that cloning and sequencing of the MelARV insertion
sites in murine melanomas might shed a new light on understanding the
genetic mechanisms of melanoma formation. In the present study, we have
attempted to clone and sequence the insertion sites of MelARV in B16
melanoma cells.
 |
MATERIALS AND METHODS |
Cell lines and plasmids.
The B16BL6 melanoma line
(hereafter referred as BL6 line) was selected from B16F10 melanoma
cells for high invasiveness and was kindly provided by Isaiah Fidler
(M.D. Anderson Cancer Center, Houston, Tex.) (10). The BL6-8
clone was isolated from the parental B16BL6 line by limiting dilution
(8). These melanoma cells were tested and proved to be free
of the following murine viruses: respiratory enteric orphan virus type
3, pneumonia virus, K virus, Theiler's murine encephalomyelitis virus,
Sendai virus, minute virus of mice, mouse adenovirus, mouse hepatitis
virus, lymphocytic choriomeningitis virus, ectromelia virus, and
lactate dehydrogenase-elevating virus (Microbiological
Associates, Walkersville, Md.). They were maintained in vitro in RPMI
1640 supplemented with 10% fetal bovine serum, glutamine,
streptomycin, and penicillin (all from Life Technologies, Inc.,
Gaithersburg, Md.). The melanocyte line Melan-A was generated from the
skin of 18-day-old embryos of C57BL/6 (2) and was a gift
from D. Bennett (St. George's Hospital Medical School, London, United
Kingdom). Melan-A melanocytes were maintained in Bennett's medium,
which is minimum essential medium supplemented with 5% fetal calf
serum, sodium pyruvate, sodium, bicarbonate, 2-mercaptoethanol (100 µM), antibiotics, and TPA (200 µM), adjusted to pH 6.9. Another
melanocyte line, Melan-BL, was established from the skin of newborn
C57/BL6 mice and kindly provided by R. Halaban (Yale University, New
Haven, Conn.). Melan-BL was maintained in Ham's F-10 medium
supplemented with 5% FCS, 10% horse serum, and 100 nM TPA.
Melan-A melanocytes that were transformed by
v-rasHa transfection (40) were termed
Mel-ras. Meli-A1 and Meli-BL melanomas were obtained by infection of
the Melan-A line and Melan-BL lines with MelARV (27). All
melanomas were maintained in complete RPMI 1640 medium. Plasmid
pB6eco-fl was kindly provided by Steven King (Wayne State University,
Detroit, Mich.). The plasmid contains on a pBR322 backbone a 20-kb
insert, of which 8.8 kb is the full-length genome of the Emv-2
ecotropic retrovirus. The rest of the insert represents partial
cellular flanking sequence (17).
Sequencing of pB6eco-fl.
The nucleotide sequence of the
Emv-2 provirus and its cellular flanking regions was determined by
sequencing the pB6eco-fl plasmid. DNA sequencing was performed with the
chain terminator method (39) on an ABI 377 sequencer by a
"crawling-along" strategy (38). A pair of primers that
bind to ecotropic env gene were used to start the
"walking" sequencing strategy in a "back-to-back" manner.
Specifically, one primer (TATACGTCTCTGGACATG) lies at nucleotides 6507 to 6524 and directs the sequencing reaction toward the upstream portion of the viral genome and its 5' flanking
region. Another primer (GGTCATGTCCAGAGACG) binds the same
stretch of nucleotides but extends toward the opposite downstream
direction. The newly obtained sequences with these primers were then
utilized to design primers for the next round of sequencing. By
repeating this procedure, each clone that was subject to sequencing was
eventually sequenced to completion on both strands.
Isolation of viral RNA.
Supernatant (100 ml) was freshly
collected from BL6-8 cell culture and centrifuged at 2,000 × g for 10 min and then filtered through a 0.2-um-pore-size
microfilter. The filtrated supernatant was then subject to
ultracentrifugation at 25,000 rpm (Beckman SW28 rotor) for 3 h at
4°C. The pellet was recovered and resuspended in 1 ml of RNase-free,
10 mM Tris-HCl (pH 8.8), 1 mM EDTA, and 1% Nonidet P-40 and then
extracted three times with 1 ml of phenol-chloroform-isoamyl alcohol
(25:24:1). The resultant RNA was precipitated with ethanol and resolved
in 100 µl of DEPC treated H2O.
Long template RT-PCR amplification, cloning, and sequencing.
Long template reverse transcriptase-PCR (RT-PCR) was performed with the
One-step RT-PCR kit and the Elongase thermostable DNA polymerase (both
from Life Technologies, Inc., Md.) according to the manufacturer's
manual. Briefly, 5 µg of viral RNA was applied to a reaction mixture
containing 1× buffer, 5 U of Elongase, 1 µl of RT-Taq
enzyme mixture and 0.2 µM of each primer. The RT-PCR primers were
designed based on the consensus sequence of ecotropic retrovirus that
was originally determined on AKV MuLV (12). The upstream
primer (AACAAGGAAGTACACAGAGGCTGG) was derived from the U3
region and the downstream primer (GCAGTCAATCACTCTGAGGAGACC) was from the U5 region. The cycling parameters were as follows: 50°C for 30 min for reverse transcription, followed by 35 cycles of
94°C for 30 s, 57°C for 30 s, and 70°C for 5 min.
The recovery and cloning of the long-template RT-PCR product were
performed with the TOPO XL PCR Cloning Kit (Invitrogen, Calif.).
Briefly, the amplified DNA was recovered from 0.7% agarose gel after
electrophoresis, purified with a spin column provided in the kit, and
ligated to a precut vector pCR-XL-TOPO (Invitrogen) with two overhung
T's. The ligation reaction was then electroperforated into competent
Escherichia coli cells and plated on LB-agar petri dishes.
The resultant colonies were screened by hybridizing with an ecotropic
retrovirus-specific env probe (pEc-B4) to obtain ecotropic
retrovirus containing clones (3, 4). The RT-PCR and cloning
were repeated to assure the accuracy of the amplification.
A crawling-along strategy similar to that used in pB6eco-fl sequencing
was applied to sequence the positive clones obtained
from the above
cloning procedures. Plasmid DNA was purified with
the Plasmid Miniprep
Kit from Qiagen (California). The first round
of sequencing was started
from both ends of the viral inserts,
primed by the following sequencing
primers, respectively: the
M13 reverse sequencing primer and the T7
sequencing primer (both
from Life Technologies). The newly obtained
sequences with these
primers were then utilized to design primers for
the next round
of sequencing. By repeating this procedure, the insert
of each
clone that was subject to sequencing was eventually sequenced
to completion on both strands. Sequence analysis was executed
with the
PC/Gene software (IntelliGenetics) and the BLAST program
provided by
National Center for Biotechnology Information, available
on the
Internet.
Inverse PCR.
High-molecular-weight DNA was isolated from
BL6-8 cells by proteinase K digestion and phenol-chloraform extraction
and resuspended in H2O (38). DNA (1 µg) was
subject to HindIII restriction enzyme digestion,
followed by phenol-chloroform extraction. The
HindIII-digested DNA was then added to a self-ligation
reaction with T4 DNA ligase to generate a circular molecule that
sequentially contains the 3' cellular flanking sequence, partial
pol region, the gag region, and the
env region of MelARV. Two inverse primers P4
(GAAAGTCGGAGAGCCAGGTGGACC) and GSP27
(TGGGTCCTACTATTTGGCCGC) (Fig.
1) were designed in accordance with the
nucleotide sequences of the pol and env regions
of MelARV that were determined in this study. The PCR was performed
with Taq DNA polymerase and the following cycling
parameters: 94°C for 30 s, 57°C for 30 s, 72°C for 3 min for 30 cycles.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 1.
Inverse PCR used to clone MelARV flanking sequences. (A)
Design of inverse PCR. HindIII restriction sites are
marked. P4 and GSP27, two primers used in the inverse PCR. (B) Result
of inverse PCR.
|
|
To directly sequence the products of inverse PCRs, the amplified
bands were recovered from an agarose gel with a GenElute
Agarose Spin
Column (Suppleco), according to the manufacturer's
instruction.
The purified DNA samples were then subject to a sequencing
reaction
containing a sequencing primer that is nested to the
inverse PCR
primer.
Northern blot analysis.
Northern analysis was performed as
described previously (26). Cellular total RNA was isolated
by the phenol-chloroform extraction method (38). The
extracted RNAs were separated on 1% agarose gel containing
formaldehyde and then transferred to a nylon membrane. The
c-maf probe used in the Northern blot hybridization that
represents the 5' 300-bp portion of the murine c-maf gene
was kindly given by L. Glimcher (Harvard Medical School, Boston,
Mass.). After the blot membrane hybridized with the c-maf
probe was exposed to an X-ray film, it was stripped with 1% sodium
dodecyl sulfate and a 0.01× SSC (1× SSC is 0.15 M NaCl plus 0.015 M
sodium citrate) solution at 100°C twice for 5 min, followed by a
rehybridization with a murine DNA polymerase gamma full-length cDNA
probe that was a gift from H. P. Zassenhaus (St. Louis University, St.
Louis, Mo.).
Nucleotide sequence accession number.
The sequence of the
MelARV genome was deposited in GenBank under accession no.
U63133.
 |
RESULTS |
Nucleotide sequence of MelARV.
Retroviral particles
were obtained from the cell-free supernatant of cultured BL6-8 melanoma
cells, and the retroviral RNA was isolated and used as a template for
RT-PCR amplification. With a long-template RT-PCR method, we cloned and
sequenced the full-length cDNA copy of the MelARV genome. The complete
sequence of the MelARV genome consists of 8,274 nucleotides (nt). It
contains 5' and 3' long terminal repeats (LTRs) and gag-pol
and env coding regions that are 5,205 and 2,010 nt in
length, respectively. The primary structure of these regions appears to
have full coding capacity as a retrovirus. The coding sequences for all
typical retroviral proteins, such as a gag gene coding for
matrix protein (p15), protein p12, and capsid protein (p30), a
pol gene coding for Pol protein, and an env gene
coding for SU protein (gp70) and TM protein (p15E), are found to be
organized in the typical order along the genome. Sequence analysis
revealed that MelARV is a typical ecotropic retrovirus that does
not contain an intraviral EcoRI restriction site. A
PstI site was found only in the LTRs, and
HindIII site was found in the pol region.
Furthermore, the env region contains sequences that are
typical for ecotropic retroviruses. However, the U3 region of MelARV
compared to that of fully sequenced Emv-11 contains a 99-bp deletion.
Comparative nucleotide sequence analysis of MelARV and Emv-2
provirus.
It is believed that the Emv-2 locus exists in all cells
of C57B/6 mice and is the only ecotropic endogenous provirus in normal cells of this origin (13). The sequence information of this provirus, obviously, is of importance since it could serve as one of
the best references in comparative studies of other ecotropic viruses
that originate in B16 melanomas. The sequence of the Emv-2 virus,
however, was only partially determined by King et al. (17, 18), with a total length of 2,422 bp, covering areas that
distribute discontinuously along the Emv-2 genome (bp 1 to 452, 2670 to
3719, 4168 to 4360, 4568 to 4632, 6004 to 6078, 6543 to 6641, 7111 to 7363, 7824 to 7922, and 8191 to 8326). Therefore, we attempted to fully
sequence the Emv-2 genome cloned in the pB6eco plasmid. Our sequence
analysis indicates that Emv-2 has a total length of 8,274 nt, with a
perfect match to the partial sequences of Emv-2 virus previously
reported by King et al. (17, 18). To characterize the Emv-2
sequence, it was compared with the Emv-11 virus (also designated
AKV-623) (12), which is the only completely sequenced
ecotropic retrovirus according to GenBank and has been widely
used as a standard reference in structural and functional studies on
endogenous retroviruses. The alignment of these two sequences between
Emv-2 and Emv-11 reveals an overall homology as high as 98.38% (8,140 identical nt out of 8,274 nt in total) (Table
1). The most striking
nucleotide difference is a 99-bp deletion in the Emv-2 U3 region,
corresponding to nt 8035 to 8133 in the Emv-11, which is virtually one
of two copies of the enhancer sequence in this region. In the
coding regions, it is independently confirmed here that the
pol region of Emv-2 carries a G to C mutation at the nt
3576, which has been considered responsible for the deficiency of
the Emv-2 virus due to the resultant Ala to Pro substitution
(17). The other variations, as shown in Table 1, basically
scatter around the entire genome, many of which lead to amino acid
substitutions.
The highly productive MelARV probably emerged in B16 melanoma cells
from the endogenous ecotropic Emv-2 provirus. Also of
note is that the
deduced Gag proteins of Emv-2 and MelARV reveal
a greater difference
than those between Emv-11 and Emv-2 (2.05%
versus 0.37%). Most of
their amino acid differences are due to
alterations present in the
coding region of the major core protein,
p30 (nt 1280 to 2068) (Table
1). The p30 protein contains N/B
tropism determinants (
35).
Because the Emv-2 is an N-tropic
virus (
18), these
alterations must occur to restore efficient
viral growth in the
Fv-1b/b strain of C57B/6 mice. Hence, our data
suggest that the changes
in p30 are a part of the molecular basis for
the restoration of
the productivity of the MelARV during its emergence
in melanoma
or premalignant
cells.
The variation rate between the
env genes of Emv-2 and MelARV
is the lowest (0.4%) compared with the
gag and
pol other two
coding regions (3.4 and 1.56%, respectively)
(Table
1). However,
seven of eight nucleotide changes in the
env region of MelARV
give rise to an amino acid alteration.
As a result, the deduced
amino acid sequences of MelARV and Emv-2 Env
proteins reveal a
moderate heterology of 1.05%, which is
significantly higher than
the difference between Emv-11 and Emv-2. In
addition, five of
the seven changed amino acids are present in gp70
(Table
1),
which is the very molecule that is most likely engaged in
extracellular
molecular interactions. We previously found that the
env gene
of MelARV encodes the cell surface MAA recognizable
by MM2-9B6
MAb, which has long been used as a powerful tool in
experimental
studies of B16 melanoma (
9,
24, and
25).
According to our
data, it is likely that structural modifications in
MelARV gp70
caused by the observed sequence changes resulted in
the emergence
of the specific MAA
epitope.
Since the highly productive MelARV that emerged in B16BL6 melanoma
cells is an ecotropic retrovirus, it could be that the
MelARV is a
variant virus derived from the Emv-2 locus during
the development of
melanoma. This hypothesis is supported by the
fact that MelARV,
like Emv-2, also carries the 99-bp deletion
in its U3 region, but
Emv-11 which represents an ecotropic virus
of AKR mice has a
duplication of this sequence. As a concomitant
result, the difference
in the LTRs between Emv-2 and MelARV (0.36%)
appears much lower
than that between MelARV and Emv-11 (9.27%)
(Table
2).
As shown in Table
2, the overall difference between Emv-2 and MelARV is
1.49% at the nucleotide level and 1.29% at the deduced
amino acid
level. Most noteworthy among all the differences is
probably the C to G
reversion at position 3576 in the
pol region
of MelARV
(Table
1), consistent with the previous conclusion
that the mutation at
this position contributes to the deficiency
of the Emv-2 provirus
(
17).
Identification of MelARV insertion sites.
Sequence analysis
indicates that MelARV does not contain an oncogene. Its possible
involvement in malignant transformation could be due to its insertion
in cellular oncogenes or suppressor genes and the resultant changes in
the expression or functions of these genes or their products.
Therefore, we attempted to clone and sequence the MelARV insertion
sites in BL6 melanoma cells. Based on our Southern blot analysis of the
HindIII-digested genomic DNA, we estimated that the BL6
melanoma cell line contains at least four ecotropic proviruses in its
genome (26, 30). One of them is Emv-2, which was shown as a
7.0-kb band on the Southern blot and was found in DNAs from all normal
cells (30), consistent with all earlier studies (13,
28). In addition, several HindIII-digested fragments shorter than 7.0 kb (about 6.5 and 6.0 kb) and another of
about 11.0 kb were found when DNA from BL6 melanoma cells was analyzed.
By sequencing the pB6eco-fl plasmid, we obtained the 5' and 3'
flanking sequences of Emv-2 proviruses, with a length of 7 and 8 kb, respectively. Within the 15-kb flanking region sequenced so far, no
significant homology has been found to sequences in any of the GenBank
collections and no open reading frame longer than 40 amino acids has
been identified, suggesting that Emv-2 is inserted into a region
that lacks coding capacity.
Since Emv-2 is a single copy of an ecotropic provirus in C57B/6 mice
that is defective and unable to produce replication-competent
retroviral particles, we reasoned that MelARV might have been
produced
from some or all of the other three ecotropic proviral
loci in the BL6
melanoma genome. To characterize these integration
sites, we applied
inverse PCR on the artificially circulated genomic
DNA derived from the
BL6-8 melanoma clone. The isolated DNA was
digested with the
HindIII restriction enzyme, circulated, and
used as a
template in the inverse PCR. Two amplification products
were obtained
from the inverse PCR, with sizes of 1.6 and 2.1
kb, respectively. The
respective sizes of these two bands are
in accordance with flanking
sequences of the 6.5- and 6.0-kb bands
of the MelARVs on the
HindIII-digested Southern blot pattern previously
described (
26).
Nucleotide sequences of the inverse PCR products were determined. The
1.6-kb band contains a 230-bp nonviral sequence. A search
of GenBank
showed that it represents the 3' end of the c-
maf
proto-oncogene
(GenBank accession no.
S74567). As shown in Fig.
2, MelARV
is inserted between the nt 1973 and 1974. The c-
maf gene codes
for a basic region/leucine
zipper protein that belongs to the
AP-1 family of transcription factors
(
15,
22,
31). The virus
is integrated at the end of the
fifth zipper, in the same transcription
direction as the
c-
maf gene. This gene is also characterized by
its long 3'
nontranslational sequence (NTS). As a result of the
insertion, the
last leucine codon of the leucine zippers, the
downstream 22 codons of the c-
maf gene, and the 700-bp 3' NTS
are
separated from their upstream sequences. It is known that
the
c-
maf proto-oncogene gene is at 61.0 centimorgans (cM) on
mouse chromosome 8, to which the Emv-2 provirus has also been
localized at 67.0 cM (
6). Thus, one of the MelARV proviruses
and Emv-2 are inserted in the same chromosome.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
MelARV (lowercase) insertion in the c-maf
proto-oncogene (uppercase). The insertion borders are marked with
vertical lines. All the leucines that form the zipper structure are
shown. Omitted sequences are represented by dotted lines. Nucleotides
of the c-maf gene are numbered from the A of the start
codon.
|
|
The 2.1-kb inverse PCR product represents a virus-cell junction at the
3' end of the DNA polymerase gamma gene (PolG) (GenBank
accession no.
U53584). PolG catalyzes replication of mitochondrial
DNA. This copy of
MelARV is inserted into chromosome 7 where it
is known the PolG gene is
located (
37). The insertion occurs
in the opposite
transcription direction to PolG and in the 3'
nontranslational region
of the gene, 400-bp downstream from the
stop codon TAA (Fig.
3).

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 3.
MelARV insertion in the PolG gene. Sequence of the PolG
gene (uppercase) downstream from the translation stop codon
(underlined) and the insertion junctions are shown. The viral sequence
is shown in lowercase. The insertion borders are marked with vertical
lines. Nucleotides are numbered in accordance with that of the PolG
gene sequence in GenBank (accession no. U53584).
|
|
Analysis of c-maf and DNA polymerase gamma gene
expression in melanoma cells.
To examine the potential impact of
retroviral insertion on the expression of the involved host
genes, Northern blot analysis was performed (Fig.
4). RNA from EL4.8 T-lymphoma cells
provided by L. Glimcher (Harvard Medical School, Boston, Mass.)
served as a positive control. It was found that expression of
c-maf gene was up-regulated in BL6-8, Meli-A1, and Meli-BL
melanoma cell lines. No c-maf expression was found in normal
liver cells and fibroblasts. It is of note that the Mel-ras
melanoma cells, which were derived from the Melan-A melanocyte
line transformed by the v-rasHa gene did not
express the c-maf proto-oncogene (Fig. 4). Normal melanocytes also show no expression of c-maf (data not
shown). When the same Northern blot membrane was stripped and
rehybridized with a DNA polymerase gamma probe, all tested lines showed
an equal amount of messages for the gene, indicating that expression of
the DNA polymerase gamma gene was not affected by the retroviral integration (Fig. 4).

View larger version (55K):
[in this window]
[in a new window]
|
FIG. 4.
Expression of the c-maf and DNA polymerase
gamma genes in melanoma cells. RNA was extracted from melanoma cells
(BL6-8), melanomas transformed by MelARV (Meli-A1 and Meli-BL), Mel-Ras
melanoma cells transformed by v-rasHa, and
normal C57BL/6 fibroblasts or liver cells. RNA from EL4-8 T lymphocytes
was used as a positive control. An equal amount of loaded RNAs was
shown by hybridization with a beta-actin probe (data not shown).
|
|
 |
DISCUSSION |
We have cloned and sequenced the full-length genome of the
ecotropic B-tropic MelARV, which is produced by B16 melanoma cells. B16
melanoma cells were originally derived from C57B/6 mice that contain
only one single copy of the ecotropic Emv-2 provirus that has features
of N tropism. It is very likely that the Emv-2 provirus took part in
the molecular process that resulted in the emergence of MelARV during
malignant transformation or melanoma progression. To compare the
primary structures of these two related viruses, we also completely
sequenced the Emv-2 provirus.
Our comparative study exhibits very high homologies between MelARV and
Emv-2 as well as Emv-11. However, in comparison with Emv-11, the U3
region of MelARV contains only one direct repeat. It is known that the
tandem repeat elements of MuLVs function as an enhancer and they direct
a high level of transcription in a tissue-specific manner (23,
36). It is possible that the lack of 99 bp in the LTR of MelARV
might regulate the tissue specificity of this retrovirus.
Emv-2 is a defective ecotropic provirus. In a previous study, a
mutation that inactivated the ecotropic MuLV reverse transcriptase was
mapped to nucleotide 3576, as a result of an alanine to proline substitution in the presumed tether region between the polymerase and
the RNase H domains (14, 17, 18). Accordingly, a correction of the mutation at this position must occur in the proviruses to
restore its capability of producing viral particles. Comparative analysis on the sequence data obtained in our study proved that this
has been the case in MelARV, which has an alanine rather than a proline
at the position. In addition, the Emv-2 locus is known to code for an
N-tropic ecotropic virus (35). For this virus to efficiently
grow in its Fv-1b/b host such as C57BL/6 cells,
its major core protein (p30) must be changed. Indeed, we found that
clustered alterations did occur in the deduced p30 sequence of MelARV,
reflected as a significantly higher variation rate in the region
between Emv-2 and MelARV than between Emv-2 and Emv-11.
Considering the requirement for multiple changes in both p30 and
pol genes to resume the correct functions of their products, we propose that the MelARV originated as a result of recombination between Emv-2 and an N-tropic nonecotropic endogenous virus in C57BL/6
mice. This hypothesis is further supported by the feature that the
differences between the Emv-2 and MelARV sequences are clustered in
certain areas rather than randomly spanning around the entire genome.
Consistent with our data, the emergence of productive ecotropic viruses
by recombination was also found in MuLV recovered from
radiation-induced thymomas of C57B/6 or from aged DBA/2 mice (33,
34).
The envelope protein of retrovirus is a critical molecule during viral
infection and other molecular interactions. The env gene of
MelARV has been found to code for MAA, recognizable by MM2-9B6 MAb
(26). The recognition specificity is not found on normal or
other malignant cells of C57B/6 origin, indicating that either the Env
protein of Emv-2 is not expressed or correctly presented on the cell
surface or the expressed protein structure does not contain the
recognizable epitopes. There are seven amino acid differences between
the SU proteins of the Emv-2 and the MelARV, as demonstrated in this
study. These amino acid differences might be responsible for the
appearance of the epitope that is specific for MelARV. It is of note
that the env regions of Emv-2 and Emv-11 are more homologous
and manifest differences in only three amino acids.
The biological significance of MelARV remains to be further clarified.
We previously demonstrated that in vitro infection of a normal
melanocyte line with MelARV could induce malignant transformation
(27). However, this transformation was a relatively rare
event, and in most cases infection of melanocytes resulted in
expression of MAA but without malignant transformation. Our current
data show that MelARV does not contain any oncogene and the
MelARV-induced transformation could be a result of viral insertion. We
have previously demonstrated that MelARV has been inserted in at least
three locations in the genome of B16 melanoma cells (26,
30). In this study, cloning and sequencing of the insertion sites
revealed that one copy of MelARV is inserted in the c-maf proto-oncogene and that the insertion results in overexpression of the
gene. This result suggests that the viral insertion in the melanoma
cell lines might indeed play an active role in melanoma formation by
affecting host genes such as c-maf. c-maf is the cellular counterpart of the v-maf oncogene, which was
identified in the avian retrovirus AS42 that was isolated from a
spontaneous musculoaponeurotic fibrosarcoma of a chickensso
(15, 31). Products of both genes are basic leucine zipper proteins. They belong to the AP-1 family of transcription factors and
are able to form homodimers or heterodimers with Fos and Jun oncoproteins. Overexpression of c-maf gene can cause
malignant transformation of transfected chicken fibroblasts
(15). Moreover, frequent dysregulation of the
c-maf proto-oncogene at 16q23 by translocation to an
immunoglobulin locus was recently found in human multiple myeloma cells
(5). Insertion of MelARV in the 3' end of the
c-maf coding sequence truncates the last leucine zipper
repeat as well as the extraordinarily long 3' noncoding sequence.
Although the mechanism of the c-maf overexpression resulting from this integration remains unclear, several possibilities should be
taken into consideration. While it was suggested that the last leucine
zipper is not critical to its transcription-activating activity
(22), truncation of a long 3' noncoding region could stabilize the mRNA and, in turn, could be important for oncogenic activation, as was found with the c-fos gene
(29). Furthermore, the viral LTR region contains numerous
transcription regulatory elements such as enhancers, which might also
have an impact on expression of the inserted genes. Indeed,
it was demonstrated that retrovirus insertion downstream of
the c-myc gene elevated its transcription when the provirus
was inserted in the same transcription orientation as c-myc
(32). In melanoma cells, MelARV is inserted downstream of
c-maf in the same orientation and thus might affect c-maf expression.
A MelARV provirus is also inserted in the 3' noncoding sequence of the
PolG gene, in the opposite transcription direction. The PolG gene
encodes DNA polymerase gamma, which catalyzes the replication of
mitochondria DNA. Our Northern blot analysis showed that the expression
of this gene was not affected by viral integration.
In summary, the complete genomes of MelARV and Emv-2
have been sequenced. Our data reported here provide clues to
further understanding the molecular events that occurred
during the emerging of the ecotropic retrovirus as an MelARV. This
study, by uncovering the MelARV insertion sites, has also opened an
avenue to further exploring the potential molecules involved in
melanoma formation and progression.
 |
ACKNOWLEDGMENTS |
This work was in part supported by Public Health Service
grant CA59903.
We thank Steven R. King for providing the pB6eco-fl
plasmid, Laurie Glimcher for providing the c-maf
probe, and H. Peter Zassenhaus for providing the DNA polymerase gamma
probe. We also thank Ronald C. Montelaro for comments and
fruitful discussions.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: 200 Lothrop St.,
Biomedical Science Tower/Room W1053, University of Pittsburgh Cancer Institute and Department of Pathology, University of
Pittsburgh, Pittsburgh, PA 15213. Phone: (412) 624-1490. Fax:
(412) 624-7736. E-mail: mengfeng{at}pitt.edu.
 |
REFERENCES |
| 1.
|
Askew, D. S.,
C. Bartholomew, and J. N. Ihle.
1993.
Insertional mutagenesis and the transformation of hematopoietic stem cells.
Hematol. Pathol.
7:1-22[Medline].
|
| 2.
|
Bennett, D. C.,
P. J. Cooper, and I. R. Hart.
1987.
A line of non-tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumor promoter for growth.
Int. J. Cancer.
39:414-418[Medline].
|
| 3.
|
Chan, H.,
T. Bryan,
J. Moore,
S. Staal,
W. Rowe, and M. Martin.
1980.
Identification of ecotropic proviral sequences in inbred mouse strains with a cloned subgenomic DNA fragment.
Proc. Natl. Acad. Sci. USA
77:5779-5783[Abstract/Free Full Text].
|
| 4.
|
Chattopadhyay, S.,
M. Lander,
E. Rands, and D. Lowy.
1980.
Structure of endogenous murine leukemia virus DNA in mouse genomes.
Proc. Natl. Acad. Sci. USA
77:5774-5778[Abstract/Free Full Text].
|
| 5.
|
Chesi, M.,
P. L. Bergsagel,
O. O. Shonukan,
M. L. Martelli,
L. A. Brents,
T. Chen,
E. Schrock,
T. Ried, and W. M. Kuehl.
1998.
Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.
Blood
91:4457-4463[Abstract/Free Full Text].
|
| 6.
|
Copeland, N. G.,
N. A. Jenkins,
D. J. Gilbert,
J. T. Eppig,
L. J. Maltais,
J. C. Miller,
W. F. Dietrich,
A. Weaver,
S. E. Lincoln,
R. G. Steen,
J. H. Nadeau, and E. S. Lander.
1993.
A genetic linkage map of the mouse: current applications and future prospects.
Science
262:57-66[Abstract/Free Full Text].
|
| 7.
|
Eisenthal, A.,
R. Lafreniere,
A. Lefor, and S. A. Rosenberg.
1987.
Effect of anti-B16 melanoma monoclonal antibody on established murine B16 melanoma liver metastases.
Cancer Res.
47:7140-7145.
|
| 8.
|
Gorelik, E.,
S. Peppoloni,
T. Overton, and R. Herberman.
1985.
Increase in H-2 antigen expression and immunogenicity of BL6 melanoma cells treated with N-methyl-N'-nitro-nitrosoguanidine.
Cancer Res.
45:5341-5347[Abstract/Free Full Text].
|
| 9.
|
Gorelik, E.,
G. Jay,
M. Kim,
V. J. Hearing,
A. DeLeo, and P. J. McCoy.
1991.
Effects of H-2Kb gene on expression of melanoma-associated antigen and lectin-binding sites on BL6 melanoma cells.
Cancer Res.
51:5212-5218[Abstract/Free Full Text].
|
| 10.
|
Hart, I.
1979.
The selection and characterization of an invasive variant of the BL6 melanoma.
Am. J. Pathol.
97:587-591[Abstract].
|
| 11.
|
Hearing, V. J.,
S. P. Leong,
W. D. Vieira, and L. W. Law.
1991.
Suppression of established pulmonary metastases by murine melanoma-specific monoclonal antibodies.
Int. J. Cancer
47:148-153[Medline].
|
| 12.
|
Herr, W.
1984.
Nucleotide sequence of AKV murine leukemia virus.
J. Virol.
49:471-478[Abstract/Free Full Text].
|
| 13.
|
Jenkins, N.,
N. Copeland, and B. Taylor.
1982.
Organization, distribution, and stability of endogenous ecotropic murine leukemia virus DNA sequences in chromosomes of Mus musculus J.
Virol.
43:26-36.
|
| 14.
|
Johnson, M. S.,
M. A. McClure,
D.-F. Feng,
J. Gray, and R. F. Doolittle.
1986.
Computer analysis of retroviral pol genes: assignment of enzymatic functions to specific sequences and homologies with nonviral enzymes.
Proc. Natl. Acad. Sci. USA
83:7648-7652[Abstract/Free Full Text].
|
| 15.
|
Kataoka, K.,
M. Nishizawa, and S. Kawai.
1993.
Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family.
J. Virol.
67:2133-2141[Abstract/Free Full Text].
|
| 16.
|
Keshet, E.,
R. Schiff, and A. Itin.
1991.
Mouse retrotransposons: a cellular reservoir of long terminal repeat (LTR) elements with diverse transcriptional specificities.
Adv. Cancer Res.
56:215-251[Medline].
|
| 17.
|
King, S.,
B. Berson, and R. Risser.
1988.
Mechanism of interaction between endogenous ecotropic murine leukemia viruses in (BALB/c × C57BL/6) hybrid cells.
Virology
163:1-11[Medline].
|
| 18.
|
King, S. R.,
J. M. Horowitz, and R. Risser.
1987.
Nucleotide conservation of endogenous ecotropic murine leukemia proviruses in inbred mice: implications for viral origin and dispersal.
Virology
157:543-547[Medline].
|
| 19.
|
Kozak, C. A.
1985.
Retroviruses as chromosomal genes in the mouse, Adv.
Cancer Res.
44:295-336.
|
| 20.
|
Kozak, C. A., and S. Ruscetti.
1992.
Retroviruses in rodents., p. 405-481.
In
J. A. Levy (ed.), The Retroviridae. Plenum Press, New York, N.Y.
|
| 21.
|
Kuff, E., and K. Leuders.
1988.
The intracisternal A-particle gene family: structure and functional aspects.
Adv. Cancer Res.
51:183-276[Medline].
|
| 22.
|
Kurschner, C., and J. Morgan.
1995.
The maf proto-oncogene stimulates transcription from multiple sites in a promoter that directs Purkinje neuron-specific gene expression.
Mol. Cell. Biol.
15:246-254[Abstract].
|
| 23.
|
Lawrenz-Smith, S. C.,
A. C. Massey,
D. J. Innes, and C. Y. Thomas.
1994.
Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.
J. Virol.
68:5174-5183[Abstract/Free Full Text].
|
| 24.
|
Leong, S.,
J. Muller,
R. Yetter,
E. Gorelik,
T. Takami, and V. J. Hearing.
1988.
Expression and modulation of a retrovirus-associated antigen by murine melanoma cells.
Cancer Res.
48:4954-4958[Abstract/Free Full Text].
|
| 25.
|
Li, M.,
J. Muller,
V. Rao,
V. J. Hearing,
K. Leuders, and E. Gorelik.
1996.
Loss of intracisternal A-type retroviral particles (IAPs) in BL6 melanoma cells transfected with MHC class I genes.
J. Gen. Virol.
77:2757-2765[Abstract/Free Full Text].
|
| 26.
|
Li, M.,
J. Muller,
F. Xu,
V. J. Hearing, and E. Gorelik.
1996.
Inhibition of melanoma-associated antigen expression and ecotropic retrovirus production in B16BL6 melanoma cells transfected with major histocompatibility complex class I genes.
Cancer Res.
56:4464-4474[Abstract/Free Full Text].
|
| 27.
|
Li, M.,
F. Xu,
J. Muller,
V. J. Hearing, and E. Gorelik.
1998.
Ecotropic C-type retrovirus of B16 melanoma and malignant transformation of normal melanocytes.
Int. J. Cancer
76:430-436[Medline].
|
| 28.
|
Lowy, D. R.,
E. Rands,
S. K. Chattopadhyay,
C. F. Garon, and G. L. Hager.
1980.
Molecular cloning of infectious integrated murine leukemia virus DNA from infected mouse cells.
Proc. Natl. Acad. Sci. USA
77:614-618[Abstract/Free Full Text].
|
| 29.
|
Miller, A. D.,
T. Curran, and I. M. Verma.
1984.
c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene.
Cell
36:51-60[Medline].
|
| 30.
|
Muller, J.,
A. S. Khan,
M. Li,
V. Rao,
V. J. Hearing, and E. Gorelik.
1996.
Phenotypic changes and loss of melanoma-specific endogenous C-type retroviruses in BL6 melanoma cells transfected with the H-2Kb gene.
Melanoma Res.
6:101-111[Medline].
|
| 31.
|
Nishizawa, M.,
K. Kataoka,
N. Goto,
T. Fujiwara, and S. Kawai.
1989.
v-maf, a viral oncogene that encodes a "leucine zipper" motif.
Proc. Natl. Acad. Sci. USA
86:7711-7715[Abstract/Free Full Text].
|
| 32.
|
Payne, G. S.,
J. M. Bishop, and H. E. Varmus.
1982.
Multiple arrangements of viral DNA and an activated host oncogene in bursal lymphomas.
Nature
295:209-214[Medline].
|
| 33.
|
Rassart, E.,
P. Sander-Minstry,
G. Lemay,
L. DesGroseillers, and P. Jolicoeur.
1983.
New class of leukemogenic ecotropic recombinant murine leukemia virus isolated from radiation-induced thymomas of C57BL/6 mice.
J. Virol.
45:565-575[Abstract/Free Full Text].
|
| 34.
|
Rassart, E.,
M. Shang,
Y. Boie, and P. Jolicoeur.
1986.
Studies on emerging radiation leukemia virus variants in C57BL/Ka mice.
J. Virol.
58:96-106[Abstract/Free Full Text].
|
| 35.
|
Risser, T.,
J. M. Horowitz, and J. McCubrey.
1983.
Endogenous mouse leukemia viruses.
Annu. Rev. Genet.
17:85-121[Medline].
|
| 36.
|
Rosen, C. A.,
W. A. Haseltine,
J. Lenz,
T. Ruprecht, and M. W. Cloyd.
1985.
Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences.
J. Virol.
55:862-866[Abstract/Free Full Text].
|
| 37.
|
Rosenberg, N., and P. Jolicoeur.
1997.
Retroviral pathogenesis, p. 475-585.
In
J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
|
| 38.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
|
| 39.
|
Sanger, F. S.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 40.
|
Tsukamoto, K.,
M. Ueda, and V. J. Hearing.
1992.
Melanogenesis in murine melanocytes is suppressed by infection with the v-rasHa oncogene.
Pigment Cell Res. Suppl.
2:181-184.
|
| 41.
|
Zullo, S. J.,
L. Butler,
R. J. Zahorchak,
M. Macville,
C. Wilkes, and C. R. Merril.
1997.
Localization by fluorescence in situ hybridization (FISH) of human mitochondrial polymerase gamma (PolG) to human chromosome band 15q24 q26, and of mouse mitochondrial polymerase gamma (Polg) to mouse chromosome band 7E, with confirmation by direct sequence analysis of bacterial artificial chromosomes (BACs).
Cytogenet. Cell Genet.
78:281-284[Medline].
|
Journal of Virology, November 1999, p. 9178-9186, Vol. 73, No. 11
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Buscher, K., Trefzer, U., Hofmann, M., Sterry, W., Kurth, R., Denner, J.
(2005). Expression of Human Endogenous Retrovirus K in Melanomas and Melanoma Cell Lines. Cancer Res.
65: 4172-4180
[Abstract]
[Full Text]
-
Mangeney, M., Pothlichet, J., Renard, M., Ducos, B., Heidmann, T.
(2005). Endogenous Retrovirus Expression Is Required for Murine Melanoma Tumor Growth In vivo. Cancer Res.
65: 2588-2591
[Abstract]
[Full Text]
-
Turcotte, K., Gauthier, S., Tuite, A., Mullick, A., Malo, D., Gros, P.
(2005). A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice. JEM
201: 881-890
[Abstract]
[Full Text]
-
Muster, T., Waltenberger, A., Grassauer, A., Hirschl, S., Caucig, P., Romirer, I., Fodinger, D., Seppele, H., Schanab, O., Magin-Lachmann, C., Lower, R., Jansen, B., Pehamberger, H., Wolff, K.
(2003). An Endogenous Retrovirus Derived from Human Melanoma Cells. Cancer Res.
63: 8735-8741
[Abstract]
[Full Text]
-
Nelson, P. S., Clegg, N., Arnold, H., Ferguson, C., Bonham, M., White, J., Hood, L., Lin, B.
(2002). The program of androgen-responsive genes in neoplastic prostate epithelium. Proc. Natl. Acad. Sci. USA
99: 11890-11895
[Abstract]
[Full Text]
-
Kataoka, K., Yoshitomo-Nakagawa, K., Shioda, S., Nishizawa, M.
(2001). A Set of Hox Proteins Interact with the Maf Oncoprotein to Inhibit Its DNA Binding, Transactivation, and Transforming Activities. J. Biol. Chem.
276: 819-826
[Abstract]
[Full Text]
-
Kataoka, K., Shioda, S., Yoshitomo-Nakagawa, K., Handa, H., Nishizawa, M.
(2001). Maf and Jun Nuclear Oncoproteins Share Downstream Target Genes for Inducing Cell Transformation. J. Biol. Chem.
276: 36849-36856
[Abstract]
[Full Text]